Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease
© 2016 The Author(s).
| Authors: | , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2016 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/199826 |
| Online Access: | http://hdl.handle.net/10261/199826 |
| Access Level: | Open access |
| Keyword: | Cystic fibrosis Hyaluronan Airway inflammation Induced sputum |
| id |
ES_d102af83b0cd03fe5567a4e1eff571da |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/199826 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway diseaseLamas, AdelaidaMarshburn, JamieStober, Vandy P.Donaldson, Scott H.Garantziotis, StavrosCystic fibrosisHyaluronanAirway inflammationInduced sputum© 2016 The Author(s).Cystic fibrosis (CF) is a chronic inflammatory disease that is affecting thousands of patients worldwide. Adjuvant anti-inflammatory treatment is an important component of cystic fibrosis treatment, and has shown promise in preserving lung function and prolonging life expectancy. Inhaled high molecular weight hyaluronan (HMW-HA) is reported to improve tolerability of hypertonic saline and thus increase compliance, and has been approved in some European countries for use as an adjunct to hypertonic saline treatment in cystic fibrosis. However, there are theoretical concerns that HMW-HA breakdown products may be pro-inflammatory. In this clinical pilot study we show that sputum cytokines in CF patients receiving HMW-HA are not increased, and therefore HMW-HA does not appear to adversely affect inflammatory status in CF airways.This work was funded by the Division of Intramural Research, National Institute of Environmental Health Sciences, National Institutes of Health.BioMed CentralNational Institute of Environmental Health Sciences (US)National Institutes of Health (US)Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2020202020162020info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_545bPublisher's versioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/contributionToPeriodicalhttp://hdl.handle.net/10261/199826reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/10.1186/s12931-016-0442-4Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/1998262026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| title |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| spellingShingle |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease Lamas, Adelaida Cystic fibrosis Hyaluronan Airway inflammation Induced sputum |
| title_short |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| title_full |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| title_fullStr |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| title_full_unstemmed |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| title_sort |
Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease |
| dc.creator.none.fl_str_mv |
Lamas, Adelaida Marshburn, Jamie Stober, Vandy P. Donaldson, Scott H. Garantziotis, Stavros |
| author |
Lamas, Adelaida |
| author_facet |
Lamas, Adelaida Marshburn, Jamie Stober, Vandy P. Donaldson, Scott H. Garantziotis, Stavros |
| author_role |
author |
| author2 |
Marshburn, Jamie Stober, Vandy P. Donaldson, Scott H. Garantziotis, Stavros |
| author2_role |
author author author author |
| dc.contributor.none.fl_str_mv |
National Institute of Environmental Health Sciences (US) National Institutes of Health (US) Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Cystic fibrosis Hyaluronan Airway inflammation Induced sputum |
| topic |
Cystic fibrosis Hyaluronan Airway inflammation Induced sputum |
| description |
© 2016 The Author(s). |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2016 2020 2020 2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_545b Publisher's version info:eu-repo/semantics/publishedVersion |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/contributionToPeriodical |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/199826 |
| url |
http://hdl.handle.net/10261/199826 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://dx.doi.org/10.1186/s12931-016-0442-4 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
BioMed Central |
| publisher.none.fl_str_mv |
BioMed Central |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869420224773619712 |
| score |
15,811543 |